Medical Weight Loss Programs: A Growth Market
The U.S. weight loss market has entered a new phase of flat to low growth, constrained by a strong shift to do-it-yourself plans, the proliferation of free apps for smartphones, and more healthy eating by consumers. Yet, some competitors are doing well, and many untapped niches exist.
The Affordable Care Act has strengthened the value proposition of medically supervised diet programs and small-mid-sized chains are growing rapidly via franchising. The market is moving in two directions: medical and retail. Report discusses the implications of the ACA’s $1,625 Preventative Health Benefit and why it gives medical weight loss programs the edge and momentum over commercial programs.
This is a completely new analysis of the $7.8 billion U.S. medical weight loss market.
Covered dollar value & growth of the medical weight loss market segment (early 1980s to 2014, 2015 and 2019 forecasts), latest market trends and developments, growth of the retail drugstore mini-clinics diet programs, status reports for: weight loss surgery, MD-based programs, hospital and clinic-based programs, Rx diet drugs, bariatricians, VLCD programs. Franchising of medical programs, costs, avg. consumer cost of programs, avg. annual revenues per medical centers, and P&L statement.
Contains 17 in-depth competitor profiles for: Physicians Weight Loss, HMR, Optifast, Lindora Clinics, Smart For Life, Medi-Weightloss, Centers for Medical Weight Loss, Nuviva, Let’s Lose, Dr. G’s Weight Loss, JumpStartMD, Thinique, Medical Weight Loss of Michigan, CVS Health, Rite-Aid, Wal-Mart, and more.
The Affordable Care Act has strengthened the value proposition of medically supervised diet programs and small-mid-sized chains are growing rapidly via franchising. The market is moving in two directions: medical and retail. Report discusses the implications of the ACA’s $1,625 Preventative Health Benefit and why it gives medical weight loss programs the edge and momentum over commercial programs.
This is a completely new analysis of the $7.8 billion U.S. medical weight loss market.
Covered dollar value & growth of the medical weight loss market segment (early 1980s to 2014, 2015 and 2019 forecasts), latest market trends and developments, growth of the retail drugstore mini-clinics diet programs, status reports for: weight loss surgery, MD-based programs, hospital and clinic-based programs, Rx diet drugs, bariatricians, VLCD programs. Franchising of medical programs, costs, avg. consumer cost of programs, avg. annual revenues per medical centers, and P&L statement.
Contains 17 in-depth competitor profiles for: Physicians Weight Loss, HMR, Optifast, Lindora Clinics, Smart For Life, Medi-Weightloss, Centers for Medical Weight Loss, Nuviva, Let’s Lose, Dr. G’s Weight Loss, JumpStartMD, Thinique, Medical Weight Loss of Michigan, CVS Health, Rite-Aid, Wal-Mart, and more.
Executive Overview: Major Findings 1-11
Discussion of total weight loss market: diet market mega-trends: shift from diet products to services, medical programs gain momentum under ACA, what’s wrong with commercial chains, importance of counselors, franchising pros & cons, consumer clean eating trend, move to retail outlets
Outlook for 2105 diet season, discussion of rise of MLM firms, DIY trends, company programs, competition from apps.
Types of medical weight loss providers list
Tables:
2013-2014 $ value of diet products vs. services
Market revenues $ size, by segment: 201015
Forecasted growth rates for market segments: 2015-2019.
Retail Drugstore Chain Mini-Clinics 12-18
Discussion of the growth of in-store mini-clinics at drugstore chains, why the demand
Staffing by Nurses, Physicians Assistants, typical start-up costs, logistics
Growth prospects/forecasts by merchant Medicine, others
why weight loss programs are a good complement to their services and revenues.
Company Profiles
CVS Minute Clinics
RediClinics
Rite-Aid Weigh Forward Program
Walgreens
Wal-Mart Clinics
Hospital & Clinic Chains Weight Loss Programs 19-56
Types of plans offered (low-cost, moderate-cost plans, estd. no. of hospitals providing each, typical cost), Medicare new coverage
Physician-based diet programs: diet drugs/other methods used, consumer attitudes, limitations, estd. no. MDs with a weight loss program – independents vs. affiliated with chains, meds used, typical cost of MD programs
How Obamacare has provided a game-changing opportunity for MDs to add weight loss & counseling services via PAs, RDs, Nurses
Profiles of a hospital-based weight loss program: Johns Hopkins
Major Medical Chains: Lindora Clinics, Centers for Medical Weight Loss, Smart for
Life, Medi-Weightloss Clinics, Medical Weight Loss of Michigan, new chains:
Nuviva, Thinique, Dr. G’s, Let’s Lose, JumpstartMD (in-depth company descriptions, plan costs, estimated revenues, no. of centers, franchising growth strategies, etc.)
Tables: Avg. revenues per site, avg. plan cost to patient, avg. income statement, start-up
Costs for top 8 medical weight loss chains/franchises/licensors.
The Diet Drugs Market 57-77
Discussion of viewing obesity as a disease, major obesity medications used today, FDA position, role of MDs, commercial chains’ involvement with diet drugs, why it’s tougher than thought to develop anti-obesity drugs that are effective and with minimal side effects.
Status Report: Contrave, Qsymia & Belviq sales & outlooks, FDA rejections of: Acomplia, Taranabant, other Rx diet drugs
Other new obesity drugs in development: Saxenda, Beloranib, Mirabegron
Existing drugs used (Xenical, Phentermine) – descriptions
Tables prescriptions written and $ sales for: Meridia, Xenical, Phentermine, 12 other anti-obesity drugs (2003-2014), historical sales 1995-2000
Marketdata’s 2015 and 2019 outlooks for prescription diet drugs, effect of new drugs on mkt. Size, discussion of this market’s potential vs. drawbacks, overcoming MD and consumer attitudes, side effects, effectiveness. Moderate weight loss not enough for most dieters.
Bariatrician Programs 78-86
status report of profession, ASBP survey results (MDs by: age, income, size practice), how they’re trained, number practicing, certification by ASBP, use of diet drugs, treatment methods used, plan effectiveness/cost, business is up due to more surgeries, less surgeries – opinions of industry consultant.
The Bariatric Surgery Market 87-110
Discussion of gastric bypass & lapband procedures, why demand grew strongly to 2007, status report, 2014 estimated surgeries, 2015 & 2019 forecasts, costs per surgery by type payor, pros/cons, who qualifies, effect of Obamacare on coverage by 25 state exchanges
Surgery mkt. smaller than thought – better data from government/AHRQ data proves
2009-2012 DECLINE, REVISIONS OF PRIOR ESTIMATES BASED ON ASMBS ESTIMATES
Surgery utilization and outcomes, mean cost per surgery
Major insurers’ coverage today, status report, Medicare position, role of liaison firms (The
Wish Centers, Barix Clinics, Liv-Lite, Journey Lite addresses), avg. cost of surgery.
Types of surgery: Roux-en-Y, lap banding, minigastric bypass, sleeve, consumer pros/cons
Table: No. of bariatric surgeries performed: 1992-2015
Table: $ value of the market: 1992-2019 F, outlook under Obamacare
Associations: ASBS, Obesity Action Coalition, increased lobbying efforts.
VLCD/LCD Fasting Supplement Programs 111-132
Status report of low-calorie modified fasting programs in 2013-2014, effect of bariatric surgeries, outlooks by mgmt. at HMR, strong demand from hospitals for tunkey programs characterizing the mkt. (price, programs, no. of sites, increased direct-tocustomer sales)
Historical nature of market development from 1970s-1990s, enrollments, dropout/ completion rates, problem on insurance coverage, market indicators, positive & negative trends/factors.
Table: Marketdata estimates of VLCD enrollments for 1995-2015 (new vs. repeat patients, fasting vs. maintenance), $ value of mkt. for 1984-2019 F.
Company Profiles: Detailed descriptions of companies/plans, program revenues:
Health Management Resources, Optifast (Nestle)
Table: VLCD enrollments, $ mkt. value: Marketdata estimates: 2007-2014.
Reference Directory of Weight Loss Information Sources 133-137
Industry & government trade associations, journals, newsletters, magazines, consultants
Discussion of total weight loss market: diet market mega-trends: shift from diet products to services, medical programs gain momentum under ACA, what’s wrong with commercial chains, importance of counselors, franchising pros & cons, consumer clean eating trend, move to retail outlets
Outlook for 2105 diet season, discussion of rise of MLM firms, DIY trends, company programs, competition from apps.
Types of medical weight loss providers list
Tables:
2013-2014 $ value of diet products vs. services
Market revenues $ size, by segment: 201015
Forecasted growth rates for market segments: 2015-2019.
Retail Drugstore Chain Mini-Clinics 12-18
Discussion of the growth of in-store mini-clinics at drugstore chains, why the demand
Staffing by Nurses, Physicians Assistants, typical start-up costs, logistics
Growth prospects/forecasts by merchant Medicine, others
why weight loss programs are a good complement to their services and revenues.
Company Profiles
CVS Minute Clinics
RediClinics
Rite-Aid Weigh Forward Program
Walgreens
Wal-Mart Clinics
Hospital & Clinic Chains Weight Loss Programs 19-56
Types of plans offered (low-cost, moderate-cost plans, estd. no. of hospitals providing each, typical cost), Medicare new coverage
Physician-based diet programs: diet drugs/other methods used, consumer attitudes, limitations, estd. no. MDs with a weight loss program – independents vs. affiliated with chains, meds used, typical cost of MD programs
How Obamacare has provided a game-changing opportunity for MDs to add weight loss & counseling services via PAs, RDs, Nurses
Profiles of a hospital-based weight loss program: Johns Hopkins
Major Medical Chains: Lindora Clinics, Centers for Medical Weight Loss, Smart for
Life, Medi-Weightloss Clinics, Medical Weight Loss of Michigan, new chains:
Nuviva, Thinique, Dr. G’s, Let’s Lose, JumpstartMD (in-depth company descriptions, plan costs, estimated revenues, no. of centers, franchising growth strategies, etc.)
Tables: Avg. revenues per site, avg. plan cost to patient, avg. income statement, start-up
Costs for top 8 medical weight loss chains/franchises/licensors.
The Diet Drugs Market 57-77
Discussion of viewing obesity as a disease, major obesity medications used today, FDA position, role of MDs, commercial chains’ involvement with diet drugs, why it’s tougher than thought to develop anti-obesity drugs that are effective and with minimal side effects.
Status Report: Contrave, Qsymia & Belviq sales & outlooks, FDA rejections of: Acomplia, Taranabant, other Rx diet drugs
Other new obesity drugs in development: Saxenda, Beloranib, Mirabegron
Existing drugs used (Xenical, Phentermine) – descriptions
Tables prescriptions written and $ sales for: Meridia, Xenical, Phentermine, 12 other anti-obesity drugs (2003-2014), historical sales 1995-2000
Marketdata’s 2015 and 2019 outlooks for prescription diet drugs, effect of new drugs on mkt. Size, discussion of this market’s potential vs. drawbacks, overcoming MD and consumer attitudes, side effects, effectiveness. Moderate weight loss not enough for most dieters.
Bariatrician Programs 78-86
status report of profession, ASBP survey results (MDs by: age, income, size practice), how they’re trained, number practicing, certification by ASBP, use of diet drugs, treatment methods used, plan effectiveness/cost, business is up due to more surgeries, less surgeries – opinions of industry consultant.
The Bariatric Surgery Market 87-110
Discussion of gastric bypass & lapband procedures, why demand grew strongly to 2007, status report, 2014 estimated surgeries, 2015 & 2019 forecasts, costs per surgery by type payor, pros/cons, who qualifies, effect of Obamacare on coverage by 25 state exchanges
Surgery mkt. smaller than thought – better data from government/AHRQ data proves
2009-2012 DECLINE, REVISIONS OF PRIOR ESTIMATES BASED ON ASMBS ESTIMATES
Surgery utilization and outcomes, mean cost per surgery
Major insurers’ coverage today, status report, Medicare position, role of liaison firms (The
Wish Centers, Barix Clinics, Liv-Lite, Journey Lite addresses), avg. cost of surgery.
Types of surgery: Roux-en-Y, lap banding, minigastric bypass, sleeve, consumer pros/cons
Table: No. of bariatric surgeries performed: 1992-2015
Table: $ value of the market: 1992-2019 F, outlook under Obamacare
Associations: ASBS, Obesity Action Coalition, increased lobbying efforts.
VLCD/LCD Fasting Supplement Programs 111-132
Status report of low-calorie modified fasting programs in 2013-2014, effect of bariatric surgeries, outlooks by mgmt. at HMR, strong demand from hospitals for tunkey programs characterizing the mkt. (price, programs, no. of sites, increased direct-tocustomer sales)
Historical nature of market development from 1970s-1990s, enrollments, dropout/ completion rates, problem on insurance coverage, market indicators, positive & negative trends/factors.
Table: Marketdata estimates of VLCD enrollments for 1995-2015 (new vs. repeat patients, fasting vs. maintenance), $ value of mkt. for 1984-2019 F.
Company Profiles: Detailed descriptions of companies/plans, program revenues:
Health Management Resources, Optifast (Nestle)
Table: VLCD enrollments, $ mkt. value: Marketdata estimates: 2007-2014.
Reference Directory of Weight Loss Information Sources 133-137
Industry & government trade associations, journals, newsletters, magazines, consultants
